Results for “”

Entry Author Date Location
Rare Disease Biotechs Avrobio, Eidos Therapeutics File for IPOs 05/25/18 Boston
Mitek Systems Building New Business in Verifying Online Identities 05/25/18 San Diego
Bio Roundup: Brii Does China, Hemophilia Updates, Right to Try & More 05/25/18 National
Boston Tech Watch: OM1, Tidelift, Notarize, Iboss, Elucidata & More 05/25/18 Boston
Request Your Invite for Our Napa Summit, June 14-15 05/24/18 National
Paddy Power to Buy FanDuel After Supreme Court Paves Way for Betting 05/24/18 New York
Biotech IPOs Roll On as Kiniksa, Scholar Rock Get $227M Combined 05/24/18 Boston
Brii Biosciences Debuts with a China Pharma Strategy Backed by $260M 05/24/18 Raleigh Durham
A.I. for Healthcare Gets Even More Crowded as GV Invests in Owkin 05/23/18 New York
Superpedestrian Scoops Up $16.5M, Enters Bike-Sharing Frenzy 05/23/18 Boston
Gilead’s Norbert Bischofberger Named Kronos Bio CEO 05/23/18 Boston
Amid Housing Boom, Hometap Raises $12M to Buy a Piece of Your Home 05/23/18 Boston
Ahead of ASCO, Merck Touts Another Win for Lung Cancer Drug Combo 05/23/18 New York
Check Out the Agenda for New York Biotech: Bringing Back the Expats 05/23/18 National
CAR-T’s Launch, Payers vs. Gene Therapy & Photos From “What’s Hot” 05/23/18 Boston
Magenta’s Bastiano Sanna Appointed Semma Therapeutics CEO 05/21/18 Boston
Iora Health Goes Big With $100M to Advance Collaborative Care Model 05/21/18 Boston
NewStore Bags $20M After Ex-Victoria’s Secret, TJX CEOs Join Board 05/21/18 Boston
Data Could Make Roche Drug a Hemophilia Standard, But for How Long? 05/21/18 San Francisco
Microsoft Snaps Up Semantic Machines to Push Conversational A.I. 05/21/18 Boston
Fixing the Clinical Trial Bottleneck by Making Patients a Priority 05/21/18 San Diego
C4 Therapeutics Promotes Stewart Fisher to Chief Scientific Officer 05/18/18 Boston
6 Simple Steps to Avoid Becoming a Cybercrime Statistic in 2018 05/18/18 Boston
Bio Roundup: ASCO Abstracts, Migraine Drug Prices & “Blueprint” Fallout 05/18/18 National
Accent Therapeutics Debuts With $40M To Target RNA Modification 05/18/18 Boston
Amgen Migraine Drug Gets FDA Nod, First in New Class of Medicines 05/17/18 National
Underscore VC Quickly Raises $117M for Second Early-Stage Fund 05/17/18 Boston
Arevo Adds $12.5M to Expand 3D Printing into Manufacturing 05/17/18 San Francisco
MIT’s Inclusive Innovation Challenge Is Coming to Detroit in the Fall 05/17/18 Detroit Ann Arbor
Amgen Migraine Decision Looms, Maybe the Next Drug Price Fight, Too 05/16/18 National
Page 1 of 614 next page »